Nirmatrelvir/ritonavir use reduces risk for long COVID in patients with immunodeficiency is a research paper published in Journal of Human Immunity (2025). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R01MD017816-01
Underdiagnosis of primary immunodeficiency disorders among racial and ethnic minorities: Recognize and Educate
NIMHD NIH HHS
Grant: R01 MD017816
Massachusetts Life Sciences
American Academy of Allergy Asthma & Immunology
National Institute on Minority Health and Health Disparities
FWCI
0.00
Citation Percentile
0.4%
Fields of Study
Keywords